Close



Apr 23, 2024 09:00PM
Apr 19, 2024 09:00PM
Apr 19, 2024 07:15AM
Apr 19, 2024 07:13AM
Apr 12, 2024 07:30AM
Apr 10, 2024 07:03AM
Apr 10, 2024 07:02AM Ocugen, Inc. Announces Positive Scientific Advice from the European Medicines Agency Related to the Approval Pathway for OCU400—Modifier Gene Therapy for Broad Retinitis Pigmentosa Indication
Apr 8, 2024 06:32AM
Apr 8, 2024 06:30AM
Apr 2, 2024 08:00AM
Apr 2, 2024 05:48AM
Apr 1, 2024 06:08PM
Mar 18, 2024 06:31AM
Mar 18, 2024 06:30AM Ocugen, Inc. Appoints Huma Qamar, MD, MPH as Chief Medical Officer
Dec 21, 2023 06:30AM
Dec 21, 2023 06:30AM
Dec 19, 2023 07:30AM
Dec 19, 2023 07:30AM
Nov 9, 2023 06:30AM
Aug 21, 2023 04:32PM
May 5, 2023 07:00AM Ocugen Provides Business Update with First Quarter 2023 Financial Results
Apr 27, 2023 07:26AM
Apr 27, 2023 07:25AM
Apr 27, 2023 07:25AM
Mar 27, 2023 08:00AM
Mar 27, 2023 08:00AM
Mar 27, 2023 08:00AM
Feb 28, 2023 07:00AM Ocugen Provides Business Update with Fourth Quarter and Full Year 2022 Financial Results
Feb 28, 2023 07:00AM
Feb 28, 2023 05:55AM
Feb 27, 2023 05:57PM
Feb 27, 2023 05:57PM
Dec 16, 2022 06:31AM
Dec 16, 2022 06:30AM
Dec 16, 2022 06:30AM Ocugen Announces Phase 3 Confirmatory Clinical Trial Agreement for NeoCart®
Dec 15, 2022 05:15PM
Nov 8, 2022 07:30AM
Nov 8, 2022 07:30AM
Oct 6, 2022 08:00AM
Oct 6, 2022 08:00AM
Sep 1, 2022 07:31AM
Sep 1, 2022 07:30AM Ocugen Appoints Robert J. Hopkins, MD, MPH & TM, FACP, FIDSA, as Chief Medical Officer and Promotes Arun Upadhyay, PhD, to Chief Scientific Officer
Sep 1, 2022 07:30AM
Aug 5, 2022 07:30AM
May 24, 2022 07:11AM
May 24, 2022 07:11AM
May 23, 2022 09:19AM
May 23, 2022 06:37AM
May 23, 2022 06:36AM Ocugen (OCGN) Announces FDA Removes Clinical Hold on Phase 2/3 Clinical Trial for COVAXIN
May 23, 2022 06:36AM

251,865 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All